Paxis Pharmaceuticals
Boulder
About Paxis Pharmaceuticals
Paxis Pharmaceuticals Inc. manufacture and distribute cGMP API Paclitaxel, a leading cancer therapy drug. Paxis has established a strong asset base and is vertically integrated from the forest to the final API. Paxis has sound financial backing and is positioned to be the strongest supplier of taxane based pharmaceutical ingredients for many years to come.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: paxispharma.com
- Phone: (303)448-9850
Canonical: https://fsome.com/organization/paxis-pharmaceuticals-2380798 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.